Dibenzazepine derivatives and use thereof
作者： Laykea Tafesse , Stephen M. Lynch
DOI:
关键词:
摘要: The present disclosure provides dibenzazepine derivatives having Formula I or I(A): and the pharmaceutically acceptable salts solvates thereof, wherein R3a, R3b, R6, V1, V2, Z1, Z2, Z3, G are defined as set forth in specification. is also directed to use of compounds I(A), treat a disorder responsive blockade one more sodium channels. In embodiment, useful for treating pain.
lens.org 参考文章(65)
Laykea Tafesse, Jae Hyun Park, Substituted piperidines as sodium channel blockers ,(2014)
Miriam H Meisler, Jennifer A Kearney, Sodium channel mutations in epilepsy and other neurological disorders Journal of Clinical Investigation. ,vol. 115, pp. 2010- 2017 ,(2005) , 10.1172/JCI25466
Uma Srivatsa, Nitin Wadhani, Bramah N. Singh, Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm. Current Cardiology Reports. ,vol. 4, pp. 401- 410 ,(2002) , 10.1007/S11886-002-0040-6
I. Donaldson, Tegretol: A double blind trial in tinnitus Journal of Laryngology and Otology. ,vol. 95, pp. 947- 951 ,(1981) , 10.1017/S0022215100091659
Charles P. Taylor, Brian S. Meldrum, Na+ channels as targets for neuroprotective drugs. Trends in Pharmacological Sciences. ,vol. 16, pp. 309- 316 ,(1995) , 10.1016/S0165-6147(00)89060-4
Derk J. Hogenkamp, Phong Nguyen, Ji Yang, Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof ,(2001)
Mohamed Chahine, Aurelien Chatelier, Olga Babich, Johannes Krupp, Voltage-gated sodium channels in neurological disorders. Cns & Neurological Disorders-drug Targets. ,vol. 7, pp. 144- 158 ,(2008) , 10.2174/187152708784083830
J. A. Black, S. Dib-Hajj, D. Baker, J. Newcombe, M. L. Cuzner, S. G. Waxman, Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 11598- 11602 ,(2000) , 10.1073/PNAS.97.21.11598
M. A. Nassar, L. C. Stirling, G. Forlani, M. D. Baker, E. A. Matthews, A. H. Dickenson, J. N. Wood, Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 12706- 12711 ,(2004) , 10.1073/PNAS.0404915101
P. Yogeeswari, J. Ragavendran, R. Thirumurugan, A. Saxena, D. Sriram, Ion channels as important targets for antiepileptic drug design. Current Drug Targets. ,vol. 5, pp. 589- 602 ,(2004) , 10.2174/1389450043345227